The novel therapy of this peptide represents a exciting breakthrough in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide150783.designertoblog.com/73490112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment